109 related articles for article (PubMed ID: 9712048)
1. Characterization of a mobile Stat6 activation motif in the human IL-4 receptor.
Ryan JJ; McReynolds LJ; Huang H; Nelms K; Paul WE
J Immunol; 1998 Aug; 161(4):1811-21. PubMed ID: 9712048
[TBL] [Abstract][Full Text] [Related]
2. Cutting edge: effects of an allergy-associated mutation in the human IL-4R alpha (Q576R) on human IL-4-induced signal transduction.
Wang HY; Shelburne CP; Zamorano J; Kelly AE; Ryan JJ; Keegan AD
J Immunol; 1999 Apr; 162(8):4385-9. PubMed ID: 10201973
[TBL] [Abstract][Full Text] [Related]
3. IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6.
Ohmori Y; Smith MF; Hamilton TA
J Immunol; 1996 Sep; 157(5):2058-65. PubMed ID: 8757327
[TBL] [Abstract][Full Text] [Related]
4. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
Stütz AM; Woisetschläger M
J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
[TBL] [Abstract][Full Text] [Related]
5. Paired Stat6 C-terminal transcription activation domains required both for inhibition of an IFN-responsive promoter and trans-activation.
Goenka S; Youn J; Dzurek LM; Schindler U; Yu-Lee LY; Boothby M
J Immunol; 1999 Nov; 163(9):4663-72. PubMed ID: 10528163
[TBL] [Abstract][Full Text] [Related]
6. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
Friedrich K; Wietek S
Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
[TBL] [Abstract][Full Text] [Related]
7. A role for the insulin-interleukin (IL)-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate 2 and signal transducer and activator of transcription 6 pathways. Analysis by mutagenesis.
Wang HY; Zamorano J; Keegan AD
J Biol Chem; 1998 Apr; 273(16):9898-905. PubMed ID: 9545332
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis.
Mitsuyasu H; Yanagihara Y; Mao XQ; Gao PS; Arinobu Y; Ihara K; Takabayashi A; Hara T; Enomoto T; Sasaki S; Kawai M; Hamasaki N; Shirakawa T; Hopkin JM; Izuhara K
J Immunol; 1999 Feb; 162(3):1227-31. PubMed ID: 9973373
[TBL] [Abstract][Full Text] [Related]
9. Identification of a STAT6 domain required for IL-4-induced activation of transcription.
Lu B; Reichel M; Fisher DA; Smith JF; Rothman P
J Immunol; 1997 Aug; 159(3):1255-64. PubMed ID: 9233621
[TBL] [Abstract][Full Text] [Related]
10. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
11. Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts.
Kriebel P; Patel BK; Nelson SA; Grusby MJ; LaRochelle WJ
Oncogene; 1999 Dec; 18(51):7294-302. PubMed ID: 10602484
[TBL] [Abstract][Full Text] [Related]
12. The biology of Stat4 and Stat6.
Wurster AL; Tanaka T; Grusby MJ
Oncogene; 2000 May; 19(21):2577-84. PubMed ID: 10851056
[TBL] [Abstract][Full Text] [Related]
13. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
14. Sulfhydryl-2 domain-containing protein tyrosine phosphatase-1 is not a negative regulator of interleukin-4 signaling in murine mast cells.
White ED; Andrews RP; Hershey GK
J Leukoc Biol; 2001 May; 69(5):825-30. PubMed ID: 11358992
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-4-induced transcriptional activation by stat6 involves multiple serine/threonine kinase pathways and serine phosphorylation of stat6.
Pesu M; Takaluoma K; Aittomäki S; Lagerstedt A; Saksela K; Kovanen PE; Silvennoinen O
Blood; 2000 Jan; 95(2):494-502. PubMed ID: 10627454
[TBL] [Abstract][Full Text] [Related]
16. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites.
Schaffer A; Cerutti A; Shah S; Zan H; Casali P
J Immunol; 1999 May; 162(9):5327-36. PubMed ID: 10228008
[TBL] [Abstract][Full Text] [Related]
17. Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis.
Zamorano J; Keegan AD
J Immunol; 1998 Jul; 161(2):859-67. PubMed ID: 9670964
[TBL] [Abstract][Full Text] [Related]
18. STAT6 transcription factor binding sites with mismatches within the canonical 5'-TTC...GAA-3' motif involved in regulation of delta- and mu-opioid receptors.
Börner C; Wöltje M; Höllt V; Kraus J
J Neurochem; 2004 Dec; 91(6):1493-500. PubMed ID: 15584925
[TBL] [Abstract][Full Text] [Related]
19. IL-10 signaling via IL-10E1 is dependent on tyrosine phosphorylation in the IL-10R alpha chain in human primary prostate cancer cell lines.
Stearns ME; Hu Y; Wang M
Oncogene; 2003 Jun; 22(24):3781-91. PubMed ID: 12802285
[TBL] [Abstract][Full Text] [Related]
20. Expression of IL-4 receptor on non-bone marrow-derived cells is necessary for the timely elimination of Strongyloides venezuelensis in mice, but not for intestinal IL-4 production.
Negrão-Corrêa D; Pinho V; Souza DG; Pereira AT; Fernandes A; Scheuermann K; Souza AL; Teixeira MM
Int J Parasitol; 2006 Sep; 36(10-11):1185-95. PubMed ID: 16793046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
